

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.91327045 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.02420311 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.81835948 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.81835948 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.65155106 |
| 6 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.61498674 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 5.40743512 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.36125878 |
| 9 | valine metabolic process (GO:0006573) | 4.79558368 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 4.47612323 |
| 11 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.42870587 |
| 12 | response to peptidoglycan (GO:0032494) | 4.38685356 |
| 13 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 4.34672356 |
| 14 | natural killer cell differentiation (GO:0001779) | 4.32861868 |
| 15 | COPI coating of Golgi vesicle (GO:0048205) | 4.29590973 |
| 16 | Golgi transport vesicle coating (GO:0048200) | 4.29590973 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.00425434 |
| 18 | mannose metabolic process (GO:0006013) | 3.90324776 |
| 19 | positive thymic T cell selection (GO:0045059) | 3.87861692 |
| 20 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.83179976 |
| 21 | regulation of B cell differentiation (GO:0045577) | 3.57217884 |
| 22 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.52877729 |
| 23 | positive regulation of histone deacetylation (GO:0031065) | 3.52200952 |
| 24 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.51373587 |
| 25 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.44591562 |
| 26 | Peyers patch development (GO:0048541) | 3.44591562 |
| 27 | pentose-phosphate shunt (GO:0006098) | 3.40553685 |
| 28 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.31228466 |
| 29 | activation of MAPKKK activity (GO:0000185) | 3.30749628 |
| 30 | mature B cell differentiation involved in immune response (GO:0002313) | 3.27452813 |
| 31 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.24243111 |
| 32 | B cell mediated immunity (GO:0019724) | 3.19399868 |
| 33 | tricarboxylic acid metabolic process (GO:0072350) | 3.16897827 |
| 34 | negative regulation of cell size (GO:0045792) | 3.16756206 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08532536 |
| 36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08532536 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 3.08532536 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08532536 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.08532536 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08532536 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08237982 |
| 42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.06134384 |
| 43 | regulation of erythrocyte differentiation (GO:0045646) | 3.02154439 |
| 44 | germinal center formation (GO:0002467) | 3.01459457 |
| 45 | embryonic process involved in female pregnancy (GO:0060136) | 2.99500530 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.98055623 |
| 47 | NIK/NF-kappaB signaling (GO:0038061) | 2.96475674 |
| 48 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.96150564 |
| 49 | positive regulation of nuclease activity (GO:0032075) | 2.92959959 |
| 50 | regulation of natural killer cell differentiation (GO:0032823) | 2.92954480 |
| 51 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.88410845 |
| 52 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87419791 |
| 53 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.85930935 |
| 54 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.84954189 |
| 55 | mitochondrion transport along microtubule (GO:0047497) | 2.84954189 |
| 56 | pinocytosis (GO:0006907) | 2.84350766 |
| 57 | creatine metabolic process (GO:0006600) | 2.84027506 |
| 58 | negative regulation of bone resorption (GO:0045779) | 2.82219180 |
| 59 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.80996264 |
| 60 | histone H3 deacetylation (GO:0070932) | 2.80983456 |
| 61 | NADPH regeneration (GO:0006740) | 2.80841887 |
| 62 | maternal placenta development (GO:0001893) | 2.78944143 |
| 63 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.78798739 |
| 64 | positive regulation of interferon-alpha production (GO:0032727) | 2.77971113 |
| 65 | regulation of leukocyte degranulation (GO:0043300) | 2.77200596 |
| 66 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.76382089 |
| 67 | oxaloacetate metabolic process (GO:0006107) | 2.74820377 |
| 68 | GDP-mannose metabolic process (GO:0019673) | 2.74610415 |
| 69 | regulation of ARF GTPase activity (GO:0032312) | 2.74078731 |
| 70 | angiogenesis involved in wound healing (GO:0060055) | 2.72411898 |
| 71 | macrophage activation involved in immune response (GO:0002281) | 2.71594849 |
| 72 | thymic T cell selection (GO:0045061) | 2.70921225 |
| 73 | response to laminar fluid shear stress (GO:0034616) | 2.69927743 |
| 74 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.68880868 |
| 75 | B cell receptor signaling pathway (GO:0050853) | 2.67840916 |
| 76 | regulation of nuclease activity (GO:0032069) | 2.67175052 |
| 77 | neutrophil activation involved in immune response (GO:0002283) | 2.66696922 |
| 78 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.66694019 |
| 79 | cellular response to virus (GO:0098586) | 2.65622320 |
| 80 | positive regulation of lamellipodium assembly (GO:0010592) | 2.65205566 |
| 81 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.63192673 |
| 82 | negative regulation of B cell apoptotic process (GO:0002903) | 2.62744474 |
| 83 | regulation of chemokine biosynthetic process (GO:0045073) | 2.62718084 |
| 84 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.62528150 |
| 85 | apoptotic process involved in morphogenesis (GO:0060561) | 2.61671365 |
| 86 | regulation of mast cell degranulation (GO:0043304) | 2.60931417 |
| 87 | response to muramyl dipeptide (GO:0032495) | 2.60634661 |
| 88 | regulation of interferon-alpha production (GO:0032647) | 2.60195724 |
| 89 | positive T cell selection (GO:0043368) | 2.59892246 |
| 90 | response to type I interferon (GO:0034340) | 2.59737120 |
| 91 | barbed-end actin filament capping (GO:0051016) | 2.59649639 |
| 92 | establishment of mitochondrion localization (GO:0051654) | 2.59217027 |
| 93 | mature B cell differentiation (GO:0002335) | 2.59115118 |
| 94 | RNA destabilization (GO:0050779) | 2.57751251 |
| 95 | UV protection (GO:0009650) | 2.56871900 |
| 96 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.55469877 |
| 97 | histone H4 deacetylation (GO:0070933) | 2.55294505 |
| 98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.55239284 |
| 99 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.55239284 |
| 100 | protein retention in ER lumen (GO:0006621) | 2.54100392 |
| 101 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.53305141 |
| 102 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.52969905 |
| 103 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.52879063 |
| 104 | cellular response to type I interferon (GO:0071357) | 2.52823752 |
| 105 | type I interferon signaling pathway (GO:0060337) | 2.52823752 |
| 106 | stress fiber assembly (GO:0043149) | 2.51831098 |
| 107 | modulation by symbiont of host cellular process (GO:0044068) | 2.51809617 |
| 108 | modulation by virus of host process (GO:0019054) | 2.51794090 |
| 109 | actin nucleation (GO:0045010) | 2.50127099 |
| 110 | regulation of monocyte differentiation (GO:0045655) | 2.49897378 |
| 111 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.49844792 |
| 112 | immunoglobulin mediated immune response (GO:0016064) | 2.49386327 |
| 113 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.49126015 |
| 114 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.49126015 |
| 115 | tolerance induction (GO:0002507) | 2.48137948 |
| 116 | T cell apoptotic process (GO:0070231) | 2.47850463 |
| 117 | myeloid dendritic cell differentiation (GO:0043011) | 2.47425238 |
| 118 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.46870115 |
| 119 | positive regulation of protein deacetylation (GO:0090312) | 2.46810577 |
| 120 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.45638858 |
| 121 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.44351624 |
| 122 | ganglioside metabolic process (GO:0001573) | 2.44318507 |
| 123 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.42506534 |
| 124 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.41900152 |
| 125 | natural killer cell activation (GO:0030101) | 2.41873283 |
| 126 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.41383912 |
| 127 | growth hormone receptor signaling pathway (GO:0060396) | 2.40363958 |
| 128 | dosage compensation (GO:0007549) | 2.39890916 |
| 129 | detection of bacterium (GO:0016045) | 2.39662574 |
| 130 | snRNA metabolic process (GO:0016073) | 2.39642805 |
| 131 | cellular response to unfolded protein (GO:0034620) | 2.39269174 |
| 132 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.38857341 |
| 133 | protein insertion into membrane (GO:0051205) | 2.37703509 |
| 134 | pentose metabolic process (GO:0019321) | 2.37198959 |
| 135 | glucose catabolic process (GO:0006007) | 2.36979648 |
| 136 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.36603551 |
| 137 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.36596600 |
| 138 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.36596600 |
| 139 | negative regulation of interleukin-8 production (GO:0032717) | 2.36465195 |
| 140 | negative regulation of phagocytosis (GO:0050765) | 2.36201698 |
| 141 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.36151345 |
| 142 | T cell migration (GO:0072678) | 2.35598750 |
| 143 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.34338655 |
| 144 | positive regulation of macrophage differentiation (GO:0045651) | 2.33719604 |
| 145 | keratan sulfate catabolic process (GO:0042340) | 2.33405860 |
| 146 | T cell homeostasis (GO:0043029) | 2.33314541 |
| 147 | positive regulation of interferon-beta production (GO:0032728) | 2.32433671 |
| 148 | negative regulation of viral release from host cell (GO:1902187) | 2.32222530 |
| 149 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.31283106 |
| 150 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.30971762 |
| 151 | regulation of B cell apoptotic process (GO:0002902) | 2.30736377 |
| 152 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.29422613 |
| 153 | oligosaccharide catabolic process (GO:0009313) | 2.29304437 |
| 154 | regulation of tumor necrosis factor production (GO:0032680) | 2.28571170 |
| 155 | negative regulation of granulocyte differentiation (GO:0030853) | 2.28541049 |
| 156 | post-embryonic morphogenesis (GO:0009886) | 2.28514722 |
| 157 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.27019040 |
| 158 | detection of other organism (GO:0098543) | 2.26489816 |
| 159 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.23942673 |
| 160 | retrograde transport, endosome to Golgi (GO:0042147) | 2.23530820 |
| 161 | response to protozoan (GO:0001562) | 2.20996402 |
| 162 | regulation of necrotic cell death (GO:0010939) | 2.20258770 |
| 163 | mitochondrion localization (GO:0051646) | 2.19901756 |
| 164 | toll-like receptor 3 signaling pathway (GO:0034138) | 2.19254961 |
| 165 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.18470363 |
| 166 | protein kinase C signaling (GO:0070528) | 2.18036963 |
| 167 | regulation of regulated secretory pathway (GO:1903305) | 2.17136587 |
| 168 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.17037460 |
| 169 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.16870069 |
| 170 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.16838750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.56912206 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 3.35643599 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.18477234 |
| 4 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.97404219 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.81561684 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.78235542 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.65386387 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.59502560 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.44364604 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.42823071 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.20706037 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.19977142 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.18957638 |
| 14 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.11961800 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.08275084 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.03046326 |
| 17 | P68_20966046_ChIP-Seq_HELA_Human | 2.00642552 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00151707 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.99213061 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96871323 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96037329 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95860999 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.95846822 |
| 24 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94350164 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.90053522 |
| 26 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.89937339 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.89038971 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88593394 |
| 29 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.87673465 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.87337838 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.79108593 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.78357051 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.78255215 |
| 34 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.76879784 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.75393461 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74987429 |
| 37 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.70979433 |
| 38 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.70745702 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.70558445 |
| 40 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.69109063 |
| 41 | * MYB_26560356_Chip-Seq_TH2_Human | 1.68800698 |
| 42 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66426863 |
| 43 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63387269 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62401627 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61657589 |
| 46 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.60816430 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58803204 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58098048 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.57292371 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.56924407 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.55632110 |
| 52 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.53518792 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.52833612 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51830270 |
| 55 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.51350596 |
| 56 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.50846535 |
| 57 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.50473586 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.49404508 |
| 59 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48499917 |
| 60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.47834464 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45086143 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45044113 |
| 63 | * MAF_26560356_Chip-Seq_TH2_Human | 1.43940153 |
| 64 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.41010187 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40904380 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40775240 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.38398382 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38056204 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36859302 |
| 70 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36728215 |
| 71 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.36173586 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35164252 |
| 73 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34901273 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32692341 |
| 75 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30432965 |
| 76 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30347614 |
| 77 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.29832754 |
| 78 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.29649444 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.27626982 |
| 80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26138974 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26018263 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25353936 |
| 83 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.25315537 |
| 84 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.25155409 |
| 85 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25033676 |
| 86 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.24667226 |
| 87 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.23276212 |
| 88 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21389675 |
| 89 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20655302 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19890565 |
| 91 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19882378 |
| 92 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.19454357 |
| 93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18658305 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17851792 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17471636 |
| 96 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.17132633 |
| 97 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.16038387 |
| 98 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15676619 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15562528 |
| 100 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.14865234 |
| 101 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.14364007 |
| 102 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.14358194 |
| 103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14252050 |
| 104 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.13420723 |
| 105 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13293884 |
| 106 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.12755939 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12514855 |
| 108 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11626722 |
| 109 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11624384 |
| 110 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11532904 |
| 111 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11361397 |
| 112 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.10082444 |
| 113 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09763367 |
| 114 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09416768 |
| 115 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.08072402 |
| 116 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07814582 |
| 117 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07570424 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07471093 |
| 119 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06796642 |
| 120 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06779200 |
| 121 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06525109 |
| 122 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05577552 |
| 123 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05309133 |
| 124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04458788 |
| 125 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03236611 |
| 126 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02849891 |
| 127 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02179421 |
| 128 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01914857 |
| 129 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98773755 |
| 130 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.98689080 |
| 131 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98140624 |
| 132 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97682321 |
| 133 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97153741 |
| 134 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.97125260 |
| 135 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96673098 |
| 136 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96267263 |
| 137 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96239399 |
| 138 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96029007 |
| 139 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95722563 |
| 140 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95465009 |
| 141 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95103418 |
| 142 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94259803 |
| 143 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93160197 |
| 144 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.92832341 |
| 145 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92185680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 3.16294352 |
| 2 | MP0005451_abnormal_body_composition | 3.08918781 |
| 3 | MP0003303_peritoneal_inflammation | 2.72425849 |
| 4 | MP0000685_abnormal_immune_system | 2.61966024 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.57692469 |
| 6 | MP0003436_decreased_susceptibility_to | 2.34082974 |
| 7 | MP0004510_myositis | 2.28579400 |
| 8 | MP0009840_abnormal_foam_cell | 2.27047656 |
| 9 | MP0008260_abnormal_autophagy | 2.20671646 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.13029424 |
| 11 | MP0005387_immune_system_phenotype | 2.08056651 |
| 12 | MP0001790_abnormal_immune_system | 2.08056651 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.07588854 |
| 14 | MP0002877_abnormal_melanocyte_morpholog | 2.06302012 |
| 15 | MP0009278_abnormal_bone_marrow | 1.96341574 |
| 16 | MP0000604_amyloidosis | 1.96025324 |
| 17 | MP0003329_amyloid_beta_deposits | 1.94132113 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.89544487 |
| 19 | MP0005000_abnormal_immune_tolerance | 1.88115625 |
| 20 | MP0001800_abnormal_humoral_immune | 1.84662354 |
| 21 | MP0006054_spinal_hemorrhage | 1.83593009 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.82289230 |
| 23 | MP0002254_reproductive_system_inflammat | 1.81307096 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.80714458 |
| 25 | MP0005025_abnormal_response_to | 1.79561555 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.77923361 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.76573913 |
| 28 | MP0002723_abnormal_immune_serum | 1.76002964 |
| 29 | MP0001819_abnormal_immune_cell | 1.68620253 |
| 30 | MP0002419_abnormal_innate_immunity | 1.67479724 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.65877039 |
| 32 | MP0005671_abnormal_response_to | 1.64878321 |
| 33 | MP0004947_skin_inflammation | 1.64270630 |
| 34 | MP0002405_respiratory_system_inflammati | 1.63615450 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.63490338 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.62825345 |
| 37 | MP0003075_altered_response_to | 1.62495307 |
| 38 | MP0002398_abnormal_bone_marrow | 1.62284388 |
| 39 | MP0006082_CNS_inflammation | 1.59828379 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.59574598 |
| 41 | MP0009785_altered_susceptibility_to | 1.52661629 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.51031221 |
| 43 | MP0000681_abnormal_thyroid_gland | 1.49876581 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.49643743 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.46686024 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.45881198 |
| 47 | MP0003866_abnormal_defecation | 1.45280239 |
| 48 | MP0000716_abnormal_immune_system | 1.44390238 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.44008428 |
| 50 | MP0005310_abnormal_salivary_gland | 1.43980425 |
| 51 | MP0001853_heart_inflammation | 1.43721240 |
| 52 | MP0001348_abnormal_lacrimal_gland | 1.43010217 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.42929508 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.42929508 |
| 55 | MP0003724_increased_susceptibility_to | 1.42853138 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.42464280 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.41551167 |
| 58 | MP0002722_abnormal_immune_system | 1.41528406 |
| 59 | MP0008438_abnormal_cutaneous_collagen | 1.40264297 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.38987090 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.36595529 |
| 62 | MP0002693_abnormal_pancreas_physiology | 1.35750854 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.35461420 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.32257937 |
| 65 | MP0005023_abnormal_wound_healing | 1.31950655 |
| 66 | MP0002429_abnormal_blood_cell | 1.31317641 |
| 67 | MP0002148_abnormal_hypersensitivity_rea | 1.30680493 |
| 68 | MP0002166_altered_tumor_susceptibility | 1.29658967 |
| 69 | MP0002249_abnormal_larynx_morphology | 1.28489624 |
| 70 | MP0004858_abnormal_nervous_system | 1.26673307 |
| 71 | MP0008961_abnormal_basal_metabolism | 1.21009537 |
| 72 | MP0003283_abnormal_digestive_organ | 1.20492529 |
| 73 | MP0008469_abnormal_protein_level | 1.19314648 |
| 74 | MP0009764_decreased_sensitivity_to | 1.19185855 |
| 75 | MP0002933_joint_inflammation | 1.19149679 |
| 76 | MP0004185_abnormal_adipocyte_glucose | 1.18271751 |
| 77 | MP0001873_stomach_inflammation | 1.18223345 |
| 78 | MP0000015_abnormal_ear_pigmentation | 1.14917010 |
| 79 | MP0002139_abnormal_hepatobiliary_system | 1.13833179 |
| 80 | MP0005076_abnormal_cell_differentiation | 1.11273944 |
| 81 | MP0005360_urolithiasis | 1.10363166 |
| 82 | MP0003279_aneurysm | 1.09670415 |
| 83 | MP0001944_abnormal_pancreas_morphology | 1.05757192 |
| 84 | MP0000003_abnormal_adipose_tissue | 1.04816289 |
| 85 | MP0001849_ear_inflammation | 1.04560083 |
| 86 | MP0005166_decreased_susceptibility_to | 1.04320623 |
| 87 | MP0009643_abnormal_urine_homeostasis | 1.02360327 |
| 88 | MP0000858_altered_metastatic_potential | 1.01585676 |
| 89 | MP0003448_altered_tumor_morphology | 1.01371883 |
| 90 | MP0000490_abnormal_crypts_of | 0.99981470 |
| 91 | MP0000609_abnormal_liver_physiology | 0.99199907 |
| 92 | MP0002822_catalepsy | 0.97945036 |
| 93 | MP0005375_adipose_tissue_phenotype | 0.95991343 |
| 94 | MP0002998_abnormal_bone_remodeling | 0.95866119 |
| 95 | MP0003091_abnormal_cell_migration | 0.94582528 |
| 96 | MP0005083_abnormal_biliary_tract | 0.89524650 |
| 97 | MP0002132_abnormal_respiratory_system | 0.88430412 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.88394172 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.88122905 |
| 100 | MP0003828_pulmonary_edema | 0.87485051 |
| 101 | MP0001243_abnormal_dermal_layer | 0.86924017 |
| 102 | MP0002653_abnormal_ependyma_morphology | 0.86870636 |
| 103 | MP0010307_abnormal_tumor_latency | 0.84847996 |
| 104 | MP0003795_abnormal_bone_structure | 0.84582357 |
| 105 | MP0002019_abnormal_tumor_incidence | 0.83840177 |
| 106 | MP0000598_abnormal_liver_morphology | 0.83106070 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.82413693 |
| 108 | MP0000733_abnormal_muscle_development | 0.81863843 |
| 109 | MP0000249_abnormal_blood_vessel | 0.80047213 |
| 110 | MP0000343_altered_response_to | 0.79791671 |
| 111 | MP0004859_abnormal_synaptic_plasticity | 0.79552916 |
| 112 | MP0002928_abnormal_bile_duct | 0.79029662 |
| 113 | MP0004233_abnormal_muscle_weight | 0.78224440 |
| 114 | MP0003045_fibrosis | 0.77394934 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.76800544 |
| 116 | MP0008995_early_reproductive_senescence | 0.76701367 |
| 117 | MP0005390_skeleton_phenotype | 0.76289226 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.74981367 |
| 119 | MP0005220_abnormal_exocrine_pancreas | 0.74916942 |
| 120 | MP0002006_tumorigenesis | 0.74506187 |
| 121 | MP0001663_abnormal_digestive_system | 0.73325092 |
| 122 | MP0001915_intracranial_hemorrhage | 0.73077776 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.71030612 |
| 124 | MP0009931_abnormal_skin_appearance | 0.70655696 |
| 125 | MP0009384_cardiac_valve_regurgitation | 0.70269500 |
| 126 | MP0005670_abnormal_white_adipose | 0.68882404 |
| 127 | MP0008874_decreased_physiological_sensi | 0.68061671 |
| 128 | MP0005257_abnormal_intraocular_pressure | 0.66652557 |
| 129 | MP0008004_abnormal_stomach_pH | 0.66454389 |
| 130 | MP0005423_abnormal_somatic_nervous | 0.65449518 |
| 131 | MP0000759_abnormal_skeletal_muscle | 0.64990473 |
| 132 | MP0001764_abnormal_homeostasis | 0.63974154 |
| 133 | MP0005334_abnormal_fat_pad | 0.63838074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.79505743 |
| 2 | Interstitial pulmonary disease (HP:0006530) | 3.35335436 |
| 3 | Mucopolysacchariduria (HP:0008155) | 3.33807282 |
| 4 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.33807282 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 3.13391666 |
| 6 | Dysostosis multiplex (HP:0000943) | 3.08275110 |
| 7 | Chronic otitis media (HP:0000389) | 3.07112770 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.02914819 |
| 9 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.02110199 |
| 10 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.02110199 |
| 11 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.02110199 |
| 12 | J-shaped sella turcica (HP:0002680) | 2.99846527 |
| 13 | Cellulitis (HP:0100658) | 2.95545119 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89100650 |
| 15 | Obstructive lung disease (HP:0006536) | 2.89100650 |
| 16 | Loss of speech (HP:0002371) | 2.89006383 |
| 17 | Cerebral aneurysm (HP:0004944) | 2.87359917 |
| 18 | Abnormality of the nasal mucosa (HP:0000433) | 2.84472730 |
| 19 | Nasal polyposis (HP:0100582) | 2.83590041 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 2.82719495 |
| 21 | Agammaglobulinemia (HP:0004432) | 2.80122437 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79238421 |
| 23 | Hypertensive crisis (HP:0100735) | 2.69607931 |
| 24 | Pustule (HP:0200039) | 2.69013232 |
| 25 | Cervical subluxation (HP:0003308) | 2.67361646 |
| 26 | Neurofibrillary tangles (HP:0002185) | 2.67213088 |
| 27 | Colitis (HP:0002583) | 2.67184935 |
| 28 | Truncus arteriosus (HP:0001660) | 2.66758754 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 2.64133390 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 2.61143503 |
| 31 | Petechiae (HP:0000967) | 2.57872317 |
| 32 | Inflammation of the large intestine (HP:0002037) | 2.56855989 |
| 33 | Abnormality of the thoracic spine (HP:0100711) | 2.56033015 |
| 34 | Recurrent viral infections (HP:0004429) | 2.55422065 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.54981182 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.53938713 |
| 37 | Polygenic inheritance (HP:0010982) | 2.53100478 |
| 38 | Neuronal loss in central nervous system (HP:0002529) | 2.51985915 |
| 39 | Acute lymphatic leukemia (HP:0006721) | 2.50771911 |
| 40 | Recurrent bacterial skin infections (HP:0005406) | 2.49554382 |
| 41 | Myositis (HP:0100614) | 2.48294587 |
| 42 | Supranuclear gaze palsy (HP:0000605) | 2.46607782 |
| 43 | Protrusio acetabuli (HP:0003179) | 2.44106262 |
| 44 | Broad face (HP:0000283) | 2.42960606 |
| 45 | Thrombocytosis (HP:0001894) | 2.42801203 |
| 46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.42753777 |
| 47 | IgM deficiency (HP:0002850) | 2.42681998 |
| 48 | Hemorrhage of the eye (HP:0011885) | 2.42441986 |
| 49 | Abnormality of the columella (HP:0009929) | 2.41967390 |
| 50 | Abnormal platelet function (HP:0011869) | 2.39518568 |
| 51 | Impaired platelet aggregation (HP:0003540) | 2.39518568 |
| 52 | Exercise-induced myalgia (HP:0003738) | 2.38686138 |
| 53 | Diminished motivation (HP:0000745) | 2.38391068 |
| 54 | Increased IgE level (HP:0003212) | 2.37278192 |
| 55 | Hypoglycemic seizures (HP:0002173) | 2.32661880 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.30954993 |
| 57 | Apathy (HP:0000741) | 2.29299933 |
| 58 | Asymmetric septal hypertrophy (HP:0001670) | 2.27422163 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.26387559 |
| 60 | Hypoglycemic coma (HP:0001325) | 2.26018522 |
| 61 | Achilles tendon contracture (HP:0001771) | 2.25972317 |
| 62 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.25771605 |
| 63 | Cerebral inclusion bodies (HP:0100314) | 2.24190223 |
| 64 | Polycythemia (HP:0001901) | 2.23192852 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.22988154 |
| 66 | Late onset (HP:0003584) | 2.22272845 |
| 67 | Ulnar bowing (HP:0003031) | 2.21424491 |
| 68 | Hyperacusis (HP:0010780) | 2.18781278 |
| 69 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.17820441 |
| 70 | Emphysema (HP:0002097) | 2.17222933 |
| 71 | Increased serum ferritin (HP:0003281) | 2.16868036 |
| 72 | Recurrent bronchitis (HP:0002837) | 2.16519940 |
| 73 | Purpura (HP:0000979) | 2.14420865 |
| 74 | Bulbar palsy (HP:0001283) | 2.13618706 |
| 75 | Thin bony cortex (HP:0002753) | 2.13072818 |
| 76 | Abnormality of the Achilles tendon (HP:0005109) | 2.11195260 |
| 77 | Reticulocytosis (HP:0001923) | 2.10904838 |
| 78 | Stridor (HP:0010307) | 2.08972424 |
| 79 | Obstructive sleep apnea (HP:0002870) | 2.08630290 |
| 80 | Systemic lupus erythematosus (HP:0002725) | 2.06305827 |
| 81 | Gingivitis (HP:0000230) | 2.03384306 |
| 82 | Deep venous thrombosis (HP:0002625) | 2.01236893 |
| 83 | Distal lower limb amyotrophy (HP:0008944) | 1.99846031 |
| 84 | Joint stiffness (HP:0001387) | 1.97879808 |
| 85 | Abnormality of complement system (HP:0005339) | 1.95777533 |
| 86 | Premature rupture of membranes (HP:0001788) | 1.95253442 |
| 87 | Peritonitis (HP:0002586) | 1.95118983 |
| 88 | Vertebral compression fractures (HP:0002953) | 1.94963292 |
| 89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93445102 |
| 90 | Orchitis (HP:0100796) | 1.91875030 |
| 91 | Complement deficiency (HP:0004431) | 1.90929503 |
| 92 | Deformed sella turcica (HP:0002681) | 1.89412292 |
| 93 | Seborrheic dermatitis (HP:0001051) | 1.88293992 |
| 94 | Abnormality of the lumbar spine (HP:0100712) | 1.88220347 |
| 95 | Viral hepatitis (HP:0006562) | 1.87120173 |
| 96 | Disproportionate tall stature (HP:0001519) | 1.86959511 |
| 97 | Gastrointestinal stroma tumor (HP:0100723) | 1.86771541 |
| 98 | Verrucae (HP:0200043) | 1.86654768 |
| 99 | Papilloma (HP:0012740) | 1.86654768 |
| 100 | Ulnar deviation of the wrist (HP:0003049) | 1.86250690 |
| 101 | Severe short stature (HP:0003510) | 1.86012431 |
| 102 | Hyperthyroidism (HP:0000836) | 1.85869896 |
| 103 | Abnormality of T cell physiology (HP:0011840) | 1.85466170 |
| 104 | Supernumerary nipples (HP:0002558) | 1.85163798 |
| 105 | Abnormality of iron homeostasis (HP:0011031) | 1.84483803 |
| 106 | Self-mutilation (HP:0000742) | 1.83902362 |
| 107 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.83046024 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82948727 |
| 109 | Nonimmune hydrops fetalis (HP:0001790) | 1.82477149 |
| 110 | Recurrent skin infections (HP:0001581) | 1.82340032 |
| 111 | Abnormality of glycolipid metabolism (HP:0010969) | 1.81357658 |
| 112 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.81357658 |
| 113 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.81357658 |
| 114 | Broad distal phalanx of finger (HP:0009836) | 1.80484012 |
| 115 | Myopathic facies (HP:0002058) | 1.80175690 |
| 116 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.79845319 |
| 117 | Recurrent cutaneous fungal infections (HP:0011370) | 1.79845319 |
| 118 | Thoracolumbar scoliosis (HP:0002944) | 1.79546669 |
| 119 | Hypertriglyceridemia (HP:0002155) | 1.79226222 |
| 120 | Abnormality of the fingertips (HP:0001211) | 1.79035260 |
| 121 | Easy fatigability (HP:0003388) | 1.78941449 |
| 122 | Prolonged neonatal jaundice (HP:0006579) | 1.78826419 |
| 123 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.78607122 |
| 124 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.78607122 |
| 125 | Myocardial infarction (HP:0001658) | 1.77902826 |
| 126 | Increased variability in muscle fiber diameter (HP:0003557) | 1.77318426 |
| 127 | Abnormal large intestine physiology (HP:0012700) | 1.76000352 |
| 128 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.75982561 |
| 129 | Meningitis (HP:0001287) | 1.75891890 |
| 130 | Arterial thrombosis (HP:0004420) | 1.75717846 |
| 131 | Ragged-red muscle fibers (HP:0003200) | 1.75428356 |
| 132 | Abnormality of T cells (HP:0002843) | 1.74900902 |
| 133 | Restrictive lung disease (HP:0002091) | 1.74765434 |
| 134 | Amyloidosis (HP:0011034) | 1.74253174 |
| 135 | Aneurysm (HP:0002617) | 1.73784155 |
| 136 | Symptomatic seizures (HP:0011145) | 1.73676735 |
| 137 | Aortic aneurysm (HP:0004942) | 1.72552752 |
| 138 | Insulin resistance (HP:0000855) | 1.71702176 |
| 139 | Thoracic kyphosis (HP:0002942) | 1.70271596 |
| 140 | Hand muscle atrophy (HP:0009130) | 1.68693706 |
| 141 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.68624303 |
| 142 | Pili torti (HP:0003777) | 1.68106408 |
| 143 | Periodontitis (HP:0000704) | 1.67483632 |
| 144 | Prolonged bleeding time (HP:0003010) | 1.67404250 |
| 145 | Dilatation of the ascending aorta (HP:0005111) | 1.67390539 |
| 146 | Panhypogammaglobulinemia (HP:0003139) | 1.67284914 |
| 147 | Progressive neurologic deterioration (HP:0002344) | 1.67284188 |
| 148 | Mitral valve prolapse (HP:0001634) | 1.67145250 |
| 149 | Hematochezia (HP:0002573) | 1.66983040 |
| 150 | Chest pain (HP:0100749) | 1.66303068 |
| 151 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.66054730 |
| 152 | Osteolytic defects of the hand bones (HP:0009699) | 1.66054730 |
| 153 | Epistaxis (HP:0000421) | 1.65694568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 4.31378574 |
| 2 | TRIB3 | 3.74705548 |
| 3 | ICK | 3.42485150 |
| 4 | ERN1 | 3.40241182 |
| 5 | MAP4K1 | 3.17998243 |
| 6 | MAP3K10 | 3.11786275 |
| 7 | SMG1 | 2.78897832 |
| 8 | TAOK2 | 2.77950636 |
| 9 | JAK3 | 2.76645428 |
| 10 | PKN2 | 2.64407403 |
| 11 | EEF2K | 2.47551444 |
| 12 | NME2 | 2.05893236 |
| 13 | TYK2 | 2.03144596 |
| 14 | BTK | 1.98537634 |
| 15 | ZAP70 | 1.92711798 |
| 16 | FLT3 | 1.91365302 |
| 17 | FGFR4 | 1.87520282 |
| 18 | TBK1 | 1.84068506 |
| 19 | PASK | 1.82349604 |
| 20 | KIT | 1.71587386 |
| 21 | EPHB1 | 1.64811309 |
| 22 | RIPK1 | 1.59533314 |
| 23 | CSF1R | 1.49576930 |
| 24 | JAK1 | 1.48703091 |
| 25 | INSRR | 1.47892293 |
| 26 | TTN | 1.40934987 |
| 27 | IRAK3 | 1.40703378 |
| 28 | MAP3K3 | 1.40556593 |
| 29 | TAOK3 | 1.39814165 |
| 30 | HIPK2 | 1.37763639 |
| 31 | PRKD3 | 1.37702466 |
| 32 | MST1R | 1.36278615 |
| 33 | EPHA3 | 1.36185405 |
| 34 | MAPK15 | 1.35116007 |
| 35 | SYK | 1.33546581 |
| 36 | RPS6KA4 | 1.32577435 |
| 37 | PTK6 | 1.30886916 |
| 38 | TGFBR2 | 1.27588348 |
| 39 | BMX | 1.25275129 |
| 40 | BLK | 1.23852675 |
| 41 | STK10 | 1.22707588 |
| 42 | SIK1 | 1.20101511 |
| 43 | MARK2 | 1.18815021 |
| 44 | LRRK2 | 1.17643143 |
| 45 | TNK2 | 1.15525272 |
| 46 | JAK2 | 1.14600590 |
| 47 | MAP2K3 | 1.13853668 |
| 48 | ITK | 1.07348206 |
| 49 | IKBKE | 1.06077910 |
| 50 | MAPK12 | 1.04937047 |
| 51 | MAPK11 | 1.04119672 |
| 52 | MAP3K11 | 1.03890109 |
| 53 | PDGFRA | 1.01377497 |
| 54 | MET | 1.01133383 |
| 55 | MAPK7 | 1.00412154 |
| 56 | KDR | 0.97414882 |
| 57 | GRK6 | 0.95917590 |
| 58 | RIPK4 | 0.95530602 |
| 59 | CDK12 | 0.95031542 |
| 60 | CHUK | 0.94371714 |
| 61 | PIM1 | 0.93497069 |
| 62 | IKBKB | 0.92181797 |
| 63 | CSK | 0.91705744 |
| 64 | MARK3 | 0.90770737 |
| 65 | HCK | 0.90750083 |
| 66 | IRAK2 | 0.89197003 |
| 67 | LCK | 0.88803574 |
| 68 | SCYL2 | 0.86707372 |
| 69 | MAP3K8 | 0.86010964 |
| 70 | PIM2 | 0.82562995 |
| 71 | IRAK4 | 0.81988836 |
| 72 | TEC | 0.80856426 |
| 73 | MAP3K1 | 0.80471902 |
| 74 | MOS | 0.78732501 |
| 75 | DAPK3 | 0.77234445 |
| 76 | DYRK1B | 0.77119933 |
| 77 | DDR2 | 0.75555785 |
| 78 | MAP3K14 | 0.75148172 |
| 79 | MAP3K6 | 0.71867975 |
| 80 | MATK | 0.71335733 |
| 81 | NLK | 0.68199806 |
| 82 | ABL2 | 0.68091555 |
| 83 | TGFBR1 | 0.67889168 |
| 84 | MAPK4 | 0.67591804 |
| 85 | MAPKAPK3 | 0.67159371 |
| 86 | RPS6KA2 | 0.66402495 |
| 87 | TESK2 | 0.65765223 |
| 88 | PTK2 | 0.65761288 |
| 89 | PKN1 | 0.65251493 |
| 90 | TAOK1 | 0.65182405 |
| 91 | RPS6KA6 | 0.63096222 |
| 92 | FES | 0.62085756 |
| 93 | MTOR | 0.61831923 |
| 94 | LYN | 0.61255370 |
| 95 | SIK2 | 0.58816835 |
| 96 | PAK4 | 0.57990994 |
| 97 | ALK | 0.57643410 |
| 98 | FGFR3 | 0.57313812 |
| 99 | CDC42BPA | 0.56482127 |
| 100 | PAK2 | 0.56131981 |
| 101 | MAPKAPK2 | 0.55995540 |
| 102 | PDK1 | 0.55972641 |
| 103 | GRK7 | 0.55741284 |
| 104 | MAP2K2 | 0.54863808 |
| 105 | PRKCH | 0.53643502 |
| 106 | PRKD2 | 0.52556989 |
| 107 | PDPK1 | 0.52314182 |
| 108 | RPS6KA5 | 0.52270960 |
| 109 | DMPK | 0.51433194 |
| 110 | RPS6KA1 | 0.51198622 |
| 111 | RPS6KC1 | 0.50843483 |
| 112 | RPS6KL1 | 0.50843483 |
| 113 | TESK1 | 0.49277436 |
| 114 | NEK2 | 0.49223413 |
| 115 | PDGFRB | 0.49052913 |
| 116 | CDK6 | 0.48620884 |
| 117 | BCKDK | 0.48530146 |
| 118 | CDK19 | 0.48280945 |
| 119 | CDK4 | 0.48102691 |
| 120 | STK4 | 0.47789135 |
| 121 | CSNK1A1L | 0.46766003 |
| 122 | MAP3K7 | 0.46714930 |
| 123 | LMTK2 | 0.45171712 |
| 124 | DAPK1 | 0.44256878 |
| 125 | MAP2K6 | 0.43245045 |
| 126 | PRKG2 | 0.42814990 |
| 127 | AURKA | 0.42649683 |
| 128 | EGFR | 0.42118541 |
| 129 | CSNK1G3 | 0.41124796 |
| 130 | CDK7 | 0.40429759 |
| 131 | DYRK3 | 0.39768534 |
| 132 | PRKAA1 | 0.39161229 |
| 133 | ARAF | 0.39073050 |
| 134 | MAPK3 | 0.39024136 |
| 135 | CDK9 | 0.38344166 |
| 136 | TLK1 | 0.36322695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.01705762 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.65856120 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.58983382 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.28440184 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.26726417 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18975951 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.16182000 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.01044984 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00694155 |
| 10 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.98553862 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.86421732 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 1.85439978 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.84704890 |
| 14 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.78406698 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.75179421 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67274351 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.58828398 |
| 18 | Prion diseases_Homo sapiens_hsa05020 | 1.58827801 |
| 19 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.55047515 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.47407862 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44066754 |
| 22 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.43441383 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.41575836 |
| 24 | Apoptosis_Homo sapiens_hsa04210 | 1.41525724 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40153779 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.40017444 |
| 27 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.39342431 |
| 28 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.37231280 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.36549043 |
| 30 | Insulin resistance_Homo sapiens_hsa04931 | 1.33288032 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32601276 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31537586 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.31211262 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29998576 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.28602545 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26651896 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25315176 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24765167 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.23383639 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.20711896 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.15803261 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15214714 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12075924 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.09953178 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08730102 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06941909 |
| 47 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.04595647 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02033423 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00707837 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.00128077 |
| 51 | Lysine degradation_Homo sapiens_hsa00310 | 0.98975631 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97627107 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96041976 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95827612 |
| 55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95823616 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95191936 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.94699754 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94614351 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94478494 |
| 60 | Alcoholism_Homo sapiens_hsa05034 | 0.94054815 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93848628 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.92854549 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.91710839 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91232034 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90517108 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90513587 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90132742 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89698818 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89170568 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.88189348 |
| 71 | Asthma_Homo sapiens_hsa05310 | 0.87349791 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.86760635 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.86560575 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84520615 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83971320 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82790751 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77371270 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75693972 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75470511 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75000414 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74696844 |
| 82 | Allograft rejection_Homo sapiens_hsa05330 | 0.74532883 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73487231 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73137399 |
| 85 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72265231 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71047424 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70840331 |
| 88 | Focal adhesion_Homo sapiens_hsa04510 | 0.70625474 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.70317892 |
| 90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.69557702 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68520681 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68487894 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67508367 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67093801 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.66234942 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66096755 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65950803 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.64675053 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64229666 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62420161 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.62417467 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61657306 |
| 103 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.61570153 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60553551 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60471699 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60158761 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | 0.59801883 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59290462 |
| 109 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58351132 |
| 110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57908352 |
| 111 | Base excision repair_Homo sapiens_hsa03410 | 0.53449077 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52906885 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.52503132 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.50793908 |
| 115 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50419215 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49083341 |
| 117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48662588 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47747292 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47530739 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46865570 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46716547 |
| 122 | Protein export_Homo sapiens_hsa03060 | 0.46249701 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.45807611 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43488389 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.41584783 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41043000 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39528279 |
| 128 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38411900 |
| 129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37243438 |
| 130 | DNA replication_Homo sapiens_hsa03030 | 0.35571416 |
| 131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34809626 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31279829 |
| 133 | Ribosome_Homo sapiens_hsa03010 | 0.31265283 |

